Description: This panel discusses the new customers, new forms of risk-sharing and new ways of reinsuring these risks. It also looks at the future in this rapidly changing market. From Record of Society of Actuaries, Vol. 22, No. 2.

Description: Article from The Actuary, November 1985 – Volume No. 19, Issue No. 9 that spotlights reinsurance administration.

Description: The Bermuda International Life and Annuity Conference highlights Bermuda’s enhanced capital and solvency framework, and growing long-term (re)insurance sector.

Description: Feature article describing the issues reinsurers face when adopting IFRS 17 in regard to insurance contracts.

Description: A listing of all the events at the ReFocus 2011 meeting.

Description: Chairman’s column describing the leadership positions of the Section Council.

Description: For over a decade, life insurers have been challenged by a low interest rate environment, making it difficult to find investments with adequate yield, manage corporate spreads, and offer competitive products to consumers. While interest rates are still low compared to the early 2000’s, volatility in rates over the past year, during which the 10-year U.S. Treasury rate has increased by nearly 100 basis points, could indicate a longer-term trend of rising rates. What would a rising rate environment imply for life insurance writers? Insurers able to react to interest rate changes with agility can remain relevant in an evolving economy, protecting themselves and their policyholders. This article addresses risks and considerations faced by insurers with respect to in-force retention, pricing and product mix, and reinsurance and mergers & acquisitions.

Description: Interview (Q&A) with Charlie Shamieh, Chairman of Gen Re, against the backdrop of the COVID-19 Pandemic and its impact on Re/Insurance

Description: This article covers the inaugural edition of Re-News. From Reinsurance News, February 2005. Article from Re-news, February, 2005.

Description: The cell and gene therapy marketplace is quickly evolving and continues to grow as a risk concern for governments, health plans, stop loss insurers and reinsurers. In this webinar, we discuss currently approved tissue, cell and gene therapies, the near-term pipeline, uptake considerations, case management processes, plan document and contract considerations, risk mitigation processes and programs, and network considerations.